Mark Stenhouse - Jun 1, 2023 Form 4 Insider Report for Prometheus Biosciences, Inc. (RXDX)

Role
Chief Operating Officer
Signature
/s/ Timothy K. Andrews, attorney-in-fact for Mark Stenhouse
Stock symbol
RXDX
Transactions as of
Jun 1, 2023
Transactions value $
$0
Form type
4
Date filed
6/2/2023, 06:57 PM
Previous filing
May 30, 2023
Next filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXDX Common Stock Other $0 -14K -52.42% $0.00 12.7K Jun 1, 2023 Direct F1, F2
transaction RXDX Common Stock Other $0 +14K $0.00 14K Jun 1, 2023 By Stenhouse Family Fund F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transfer of shares from the Reporting Person to the Stenhouse Family Fund, a Charitable Gift Fund (the "Stenhouse Family Fund").
F2 Includes a total of 266 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan.
F3 The Reporting Person is a Donor of the Stenhouse Family Fund.